MedTrace Logo

Effect of Ureteral Stents Length and Location on Related Symptom

NCT05069376 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 103

Last updated 2021-10-18

No results posted yet for this study

Summary

This is a prospective randomized clinical trial, evaluating the effect of the intra-ureteral placement of the stent's distal end versus the conventional stent placement on the postoperative LUTS and pain.

Conditions

  • Lower Urinary Tract Symptoms
  • Overactive Bladder Syndrome

Interventions

DEVICE

Ureteral Stent of 5-16 or 5-18

Boston Scientific Polaris™ Ultra Ureteral Stent

DEVICE

Ureteral Stent of 5-22 or 5-24

Boston Scientific Polaris™ Ultra Ureteral Stent

Sponsors & Collaborators

  • Taipei Medical University Shuang Ho Hospital

    lead OTHER

Principal Investigators

  • Chen-Hsun Ho, MD, PhD · Shuang Ho Hospital Taipei Medical University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-06-12
Primary Completion
2020-05-25
Completion
2020-05-30
FDA Device
Yes

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05069376 on ClinicalTrials.gov